The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Rosacea Management

Phenotype-based treatment of erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea using topical agents, oral antibiotics, vasoactive medications, lasers, and trigger avoidance.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Rosacea Management?

Rosacea pathogenesis is multifactorial: dysregulated innate immunity (cathelicidin LL-37, kallikrein-5), neurovascular dysregulation (TRPV1, TRPV4 channels causing flushing), microbiome alteration (Demodex folliculorum overgrowth, helicobacter), and inflammatory pathway activation (IL-37, ROS).

Phenotypes (often overlap): (1) persistent centrofacial erythema, (2) telangiectasias, (3) papules and pustules (inflammatory phenotype), (4) phymatous changes (fibrosis, sebaceous hyperplasia — most commonly rhinophyma), (5) ocular rosacea (lid margin telangiectasia, blepharitis, conjunctivitis, keratitis, corneal scarring).

Triggers (variable patient-specific): UV light (most common), heat/cold extremes, hot beverages, spicy foods, alcohol (especially red wine), stress, exercise, menopause, certain skincare products. Trigger diary helps identify individual factors.

Symptoms

Persistent centrofacial erythema (cheeks, nose, chin, central forehead)
Telangiectasias (visible facial vessels)
Flushing episodes (transient redness with triggers)
Inflammatory papules and pustules (sterile, no comedones — distinguishing from acne)
Burning, stinging, sensitive skin
Phymatous skin thickening (rhinophyma, gnathophyma, otophyma)
Ocular: dry eye, irritation, blepharitis, telangiectatic lid margins, recurrent chalazia
Demodicosis (overlap with rosacea)

Risk Factors

Fair skin (Fitzpatrick I-II) — most common in northern European descent
Female sex (mild predominance, but rhinophyma more common in males)
Age >30 years (peak 30-60)
Family history
Photodamage history
Helicobacter pylori (controversial association)
Demodex folliculorum overgrowth
Migraine, IBD, cardiovascular comorbidity (associations reported)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent facial redness with episodes of flushing
  • Inflammatory papules/pustules on central face without comedones
  • Visible telangiectasias on cheeks/nose
  • Eye irritation with redness, lid margin involvement
  • Skin thickening on nose (early rhinophyma)
  • Failed over-the-counter rosacea or acne treatment

Treatment Methods

01
Lifestyle and skincare: gentle cleanser, fragrance-free moisturizer with ceramides/niacinamide, broad-spectrum mineral sunscreen SPF 30+ (zinc oxide, titanium dioxide), trigger identification and avoidance, lukewarm water (avoid hot)
02
Persistent erythema: topical brimonidine 0.33% gel (alpha-2 agonist, vasoconstrictor) once daily — risk of rebound erythema; oxymetazoline 1% cream (alpha-1A agonist) once daily — less rebound risk
03
Telangiectasias: pulsed dye laser (PDL) 595 nm — gold standard for vascular lesions, 2-3 sessions; intense pulsed light (IPL) — alternative; KTP 532 nm laser; Nd:YAG 1064 nm for deeper vessels
04
Papulopustular phenotype topical: ivermectin 1% cream daily (Demodex and anti-inflammatory); metronidazole 0.75-1% cream/gel BID; azelaic acid 15% gel BID; minocycline 4% foam (Zilxi)
05
Papulopustular oral: doxycycline 40 mg modified-release (subantimicrobial anti-inflammatory dosing) — preferred to avoid resistance; doxycycline 100 mg BID for 4-12 weeks for severe; minocycline alternative
06
Refractory papulopustular: isotretinoin 10-20 mg daily (low-dose, off-label) — effective for severe/refractory cases; pregnancy prevention essential
07
Ocular rosacea: lid hygiene (warm compresses, lid scrubs), artificial tears, topical ciclosporin 0.05%, oral doxycycline 40-100 mg, omega-3 supplementation; ophthalmology referral for keratitis/corneal involvement
08
Phymatous (rhinophyma): isotretinoin in early phyma; surgical management — CO2 laser ablation, electrosurgery, dermabrasion, surgical excision (cold steel) for advanced rhinophyma; sebaceous gland reduction
09
Demodex management: ivermectin 1% cream, oral ivermectin in severe cases, permethrin 5%, tea tree oil
10
Adjunctive therapies: niacinamide topical (anti-inflammatory), green tea extract, sulfur-based products, low-strength retinaldehyde (avoid retinoids in active inflammation)
11
Procedural maintenance: vascular laser maintenance every 6-12 months for persistent telangiectasias and erythema
12
Patient education: chronic disease, trigger management, sun protection paramount, gentle skincare, set realistic expectations (control vs cure), psychological impact assessment

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.